CLINICAL TRIALS PROFILE FOR OXYCODONE AND ASPIRIN (HALF-STRENGTH)

All Clinical Trials for Oxycodone And Aspirin (half-strength)

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00771758 ↗	Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis	Completed	Grünenthal GmbH	Phase 3	2008-09-01	The purpose of this study is to determine the effectiveness and safety of tapentadol immediate release (IR) as compared with placebo and oxycodone IR in patients with acute pain caused by vertebral compression fractures (VCF) associated with assumed osteoporosis for whom treatment with oral opioid analgesics is appropriate.
NCT00771758 ↗	Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis	Completed	Ortho-McNeil Janssen Scientific Affairs, LLC	Phase 3	2008-09-01	The purpose of this study is to determine the effectiveness and safety of tapentadol immediate release (IR) as compared with placebo and oxycodone IR in patients with acute pain caused by vertebral compression fractures (VCF) associated with assumed osteoporosis for whom treatment with oral opioid analgesics is appropriate.
NCT00814580 ↗	Safety and Efficacy of Tapentadol Immediate Release (IR) and Oxycodone IR for Treatment of Acute Post-op Pain Following Elective Arthroscopic (Surgery Using a Thin Flexible Scope) Shoulder Surgery	Completed	Grünenthal GmbH	Phase 3	2008-12-01	The purpose of this study is to evaluate how tapentadol immediate release (IR) and oxycodone IR treat moderate to severe post-operative pain after elective arthroscopic shoulder surgery.
NCT00814580 ↗	Safety and Efficacy of Tapentadol Immediate Release (IR) and Oxycodone IR for Treatment of Acute Post-op Pain Following Elective Arthroscopic (Surgery Using a Thin Flexible Scope) Shoulder Surgery	Completed	Ortho-McNeil Janssen Scientific Affairs, LLC	Phase 3	2008-12-01	The purpose of this study is to evaluate how tapentadol immediate release (IR) and oxycodone IR treat moderate to severe post-operative pain after elective arthroscopic shoulder surgery.
NCT01080677 ↗	Caffeine/Propranolol Intervention for Acute Migraine	Completed	Stanford University	Phase 2	2007-01-01	This is a research study to assess the safety of caffeine/propranolol at different dose levels. We want to find out what effects, good and/or bad, it has on patients and their migraines.
NCT02160301 ↗	Effect of a Multimodal Pain Regimen on Pain Control, Patient Satisfaction and Narcotic Use in Orthopaedic Trauma Patients	Withdrawn	University of North Carolina, Chapel Hill	Phase 4	2017-11-01	The study is a prospective, randomized, open-label comparison of a multimodal regimen and a standard, narcotic-based regimen for postoperative pain control in patients undergoing surgery for an operatively indicated, isolated extremity fracture. The investigators will be measuring pain levels, narcotic use, patient satisfaction, patient reported function, adverse events and fracture union. The investigators hypothesize that this multimodal regimen will lead to improved pain, less narcotic use and improved satisfaction as compared to the standard regimen.

Clinical Trial Conditions for Oxycodone And Aspirin (half-strength)

Condition Name

Condition Name for Oxycodone And Aspirin (half-strength)
Intervention	Trials
Essential Thrombocythemia	1
Migraine Disorders	1
Polycythemia Vera	1
Post Operative Pain Control	1

Condition MeSH

Condition MeSH for Oxycodone And Aspirin (half-strength)
Intervention	Trials
Pain, Postoperative	2
Migraine Disorders	1
Osteoporosis	1
Thrombocytosis	1

Clinical Trial Locations for Oxycodone And Aspirin (half-strength)

Trials by Country

Trials by Country for Oxycodone And Aspirin (half-strength)
Location	Trials
United States	24

Trials by US State

Trials by US State for Oxycodone And Aspirin (half-strength)
Location	Trials
North Carolina	3
New York	3
California	2
Arizona	2
Utah	1

Clinical Trial Progress for Oxycodone And Aspirin (half-strength)

Clinical Trial Phase

Clinical Trial Phase for Oxycodone And Aspirin (half-strength)
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	2
Phase 2	1

Clinical Trial Status

Clinical Trial Status for Oxycodone And Aspirin (half-strength)
Clinical Trial Phase	Trials
Completed	4
Unknown status	1
Withdrawn	1

Clinical Trial Sponsors for Oxycodone And Aspirin (half-strength)

Sponsor Name

Sponsor Name for Oxycodone And Aspirin (half-strength)
Sponsor	Trials
Ortho-McNeil Janssen Scientific Affairs, LLC	2
Grünenthal GmbH	2
Stanford University	1

Sponsor Type

Sponsor Type for Oxycodone And Aspirin (half-strength)
Sponsor	Trials
Industry	6
Other	5